IMMUNE-MEDIATED HEPATITIS
Clinical trials for IMMUNE-MEDIATED HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE-MEDIATED HEPATITIS trials appear
Sign up with your email to follow new studies for IMMUNE-MEDIATED HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Low-Dose steroid tame Immunotherapy's liver side effect?
Disease control Recruiting nowThis study looks at whether a low dose of a common steroid (prednisolone) can effectively treat liver inflammation (hepatitis) that occurs as a side effect of cancer immunotherapy. About 63 cancer patients who develop moderate to severe liver inflammation will receive the low-dos…
Matched conditions: IMMUNE-MEDIATED HEPATITIS
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New study aims to uncover hidden risks of cancer immunotherapy on the liver
Knowledge-focused Recruiting nowThis study observes 160 people who develop liver injury from checkpoint inhibitor cancer drugs. Researchers aim to find out how common this side effect is and what makes some people more at risk. They will also look for blood markers that could help diagnose the condition earlier…
Matched conditions: IMMUNE-MEDIATED HEPATITIS
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated May 26, 2026 03:53 UTC
-
Blood test could tell immunotherapy hepatitis apart from other liver inflammation
Knowledge-focused Recruiting nowThis study aims to find specific blood markers that can tell the difference between hepatitis caused by immune checkpoint inhibitors (a type of cancer immunotherapy) and other forms of autoimmune hepatitis. Researchers will compare blood samples from 60 adults with immunotherapy-…
Matched conditions: IMMUNE-MEDIATED HEPATITIS
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated May 18, 2026 12:13 UTC